MetLife Investment Management, LLC - GENOMIC HEALTH INC ownership

GENOMIC HEALTH INC's ticker is GHDX and the CUSIP is 37244C101. A total of 165 filers reported holding GENOMIC HEALTH INC in Q2 2018. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of GENOMIC HEALTH INC
ValueSharesWeighting
Q3 2019$834,322
+16.6%
12,3020.0%0.01%
+25.0%
Q2 2019$715,604
+15.6%
12,302
+39.3%
0.01%
+14.3%
Q1 2019$618,822
+8.8%
8,8340.0%0.01%0.0%
Q4 2018$568,998
-8.3%
8,8340.0%0.01%0.0%
Q3 2018$620,323
+12.0%
8,834
-19.6%
0.01%0.0%
Q2 2018$554,000
+100.7%
10,989
+24.7%
0.01%
+133.3%
Q1 2018$276,000
-8.3%
8,8100.0%0.00%0.0%
Q4 2017$301,0008,8100.00%
Other shareholders
GENOMIC HEALTH INC shareholders Q2 2018
NameSharesValueWeighting ↓
Baker Brothers Advisors 13,668,866$353,955,0003.71%
Camber Capital Management LP 2,458,100$63,652,0003.08%
Ghost Tree Capital, LLC 200,000$5,179,0001.50%
Tributary Capital Management, LLC 206,291$5,342,0000.78%
Motley Fool Asset Management LLC 131,935$3,416,0000.74%
CORRADO ADVISORS, LLC 40,695$1,054,0000.68%
Broadfin Capital, LLC 270,400$7,002,0000.68%
ACUTA CAPITAL PARTNERS, LLC 48,800$1,264,0000.61%
Motley Fool Wealth Management, LLC 123,018$3,186,0000.35%
TFS CAPITAL LLC 61,773$1,600,0000.29%
View complete list of GENOMIC HEALTH INC shareholders